Ünal Metin Tokat

机构：Turkish Society of Hematology, Precision for Medicine (United States) · ORCID：0000-0003-0026-368X

发表论文 38 篇 · 总被引 663 次 · h-index 9

代表论文

• Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer (2024 · Cell Death and Disease · 被引 32)
• Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer (2023 · Nature Communications · 被引 13)
• Alterations of ceramide synthesis induce PD-L1 internalization and signaling to regulate tumor metastasis and immunotherapy response (2024 · Cell Reports · 被引 11)
• Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview (2023 · JCO Precision Oncology · 被引 8)
• Therapeutic vulnerabilities and pan-cancer landscape of BRAF class III mutations in epithelial solid tumors (2024 · BJC Reports · 被引 6)
• Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers (2024 · Current Oncology · 被引 4)